Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number-Reference-Cited by-同舟云学术

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number

Published:1998-11 Issue:12 Volume:34 Page:1871-1875
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zalcberg J,Kerr D,Seymour L,Palmer M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. Grem JL, Jordan E, Robson ME, et al. Phase II study of fluorouracil, leucovorin and interferon alfa-2a in metastatic colorectal carcinoma. J Clin Oncol 1993, 11, 1737–1745.

2. Dose-response effect of adjuvant chemotherapy in breast cancer;Bonadonna;New Engl J Med,1981

3. Arriagada R, Le Chavalier T, Pignon J-P, et al. Initial chemotherapeutic doses and survival in patients with small-cell lung cancer. New Engl J Med 1993, 329, 1848–1852.

4. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group;Begg;Cancer,1983

5. Cancer chemotherapy in the elderly;Walsh;Semin Oncol,1989

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents;Pharmaceuticals;2024-08-20

2. Managing Chemotherapy-Induced Diarrhea: Efficacy of Interventions for Cancer Patients;Biosciences Biotechnology Research Asia;2024-07-01

3. The Role of Gender Pharmacogenetics in the Personalization of Drug Treatment;Journal of Pharmacology and Experimental Therapeutics;2023-03-31

4. Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping;Clinical Pharmacology & Therapeutics;2022-06-12

5. Confounding factors in the assessment of oral mucositis in head and neck cancer;Supportive Care in Cancer;2022-05-31